Coexistence of acute myeloid leukemia with a complex chromosomal translocation and monoclonal gammopathy of undetermined significance: A case report and literature review

Qiao,Xue; Geng,Li; Tian,Tian; Zhang,Jingnan; Guo,Xiaonan; Qiao,Shukai

doi:10.3892/ol.2025.14970

Coexistence of acute myeloid leukemia with a complex chromosomal translocation and monoclonal gammopathy of undetermined significance: A case report and literature review

Authors:
- Xue Qiao
- Li Geng
- Tian Tian
- Jingnan Zhang
- Xiaonan Guo
- Shukai Qiao
View Affiliations

Affiliations: Department of Hematology, Hebei Key Laboratory of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, P.R. China
Published online on: March 7, 2025 https://doi.org/10.3892/ol.2025.14970
Article Number: 224
Copyright: © Qiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Acute myeloid leukemia (AML) with chromosomal translocation t(8;21)(q22;q22.1) is a rare subtype, accounting for 4‑8% of all cases of AML. Despite its rarity, it has a favorable outcome. The translocation event culminates in the formation of the Runt‑related transcription factor 1 (RUNX1)::RUNX1 partner transcriptional co‑repressor 1 (RUNX1T1) fusion protein, which is implicated in hematopoietic differentiation and maturation. Furthermore, monoclonal gammopathy of undetermined significance (MGUS) is characterized by the presence of monoclonal immunoglobulins in the blood or urine, serum M protein level of <3 g/dl and <10% clonal plasma cells in the bone marrow, with no accompanying end‑organ damage associated with myeloma. The simultaneous occurrence of AML and MGUS is exceedingly rare. The present report describes the case of a male patient with AML and a RUNX1::RUNX1T1 fusion gene, not arising from the usual chromosomal translocation but rather from a complex translocation event involving t(8;17;21) (q22;q24;q22). The patient achieved complete remission (CR) following an idarubicin (12 mg/m², days 1‑3) + cytarabine (100 mg/m², d1‑7) regimen chemotherapy. Subsequent bone marrow monitoring revealed CR of AML during consolidation chemotherapy; however, ~5% of plasma cells were detected in the bone marrow. Flow cytology confirmed the presence of monoclonal plasma cells, and a positive hematuria immune‑fixed electrophoresis assessment led to a diagnosis of MGUS. Due to economic constraints, the patient and their family declined high‑dose cytarabine‑based combination chemotherapy and hematopoietic stem cell transplantation, opting instead for intermittent use of standard doses of anthracycline combined with cytarabine maintenance therapy. The disease relapsed after 10 months, the patient discontinued treatment and died shortly after.

View Figures

View References

1	Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, Bejar R, Berti E, Busque L, Chan JKC, et al: The 5th edition of the World Health Organization classification of haematolymphoid tumours: Myeloid and histiocytic/dendritic neoplasms. Leukemia. 36:1703–1719. 2022. View Article : Google Scholar : PubMed/NCBI
2	Sanderson RN, Johnson PR, Moorman AV, Roman E, Willett E, Taylor PR, Proctor SJ, Bown N, Ogston S and Bowen DT: Population-based demographic study of karyotypes in 1709 patients with adult acute myeloid leukemia. Leukemia. 20:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
3	Kyle RA, Durie BGM, Rajkumar SV, Landgren O, Blade J, Merlini G, Kröger N, Einsele H, Vesole DH, Dimopoulos M, et al: Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management. Leukemia. 24:1121–1127. 2010. View Article : Google Scholar : PubMed/NCBI
4	Gabert J, Beillard E, van der Velden VH, Bi W, Grimwade D, Pallisgaard N, Barbany G, Cazzaniga G, Cayuela JM, Cavé H, et al: Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe against cancer program. Leukemia. 17:2318–2357. 2003. View Article : Google Scholar : PubMed/NCBI
5	Beillard E, Pallisgaard N, van der Velden VHJ, Bi W, Dee R, van der Schoot E, Delabesse E, Macintyre E, Gottardi E, Saglio G, et al: Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR)-a Europe against cancer program. Leukemia. 17:2474–2486. 2003. View Article : Google Scholar : PubMed/NCBI
6	Wang X, Wang J, Wei S, Zhao J, Xin B, Li G, Zhao J, Wu D, Luo M, Zhao S, et al: The latest edition of WHO and ELN guidance and a new risk model for Chinese acute myeloid leukemia patients. Front Med (Lausanne). 10:11654452023. View Article : Google Scholar : PubMed/NCBI
7	Kawakami K, Nishii K, Hyou R, Watanabe Y, Nakao M, Mitani H, Murata T, Monma F, Yamamori S, Hosokai N and Miura I: A case of acute myeloblastic leukemia with a novel variant of t(8;21)(q22;q22). Int J Hematol. 87:78–82. 2008. View Article : Google Scholar : PubMed/NCBI
8	Kim H, Moon HW, Hur M, Yun YM and Lee MH: Acute myeloid leukemia with a RUNX1-RUNX1T1 t(1;21;8)(q21;q22;q22) novel variant: A case report and review of the literature. Acta Haematol. 125:237–241. 2011. View Article : Google Scholar : PubMed/NCBI
9	Udayakumar AM, Alkindi S, Pathare AV and Raeburn JA: Complex t(8;13;21)(q22;q14;q22)-a novel variant of t(8;21) in a patient with acute myeloid leukemia (AML-M2). Arch Med Res. 39:252–256. 2008. View Article : Google Scholar : PubMed/NCBI
10	Xue Y, Yu F, Xin Y, Lu D, Zou Z, Guo Y and Xie X: t(8;20)(q22;p13): A novel variant translocation of t(8;21) in acute myeloblastic leukaemia. Br J Haematol. 98:733–735. 1997. View Article : Google Scholar : PubMed/NCBI
11	Ihida F, Ueno M, Tanaka H, Makishima H, Suzawa K, Hosaka S, Hidaka E, Ishikawa M, Yamauchi K, Kitano K and Kiyosawa K: t(8;21;14)(q22;q22;q24) is a novel variant of t(8;21) with chimeric transcripts of AML1-ETO in acute myelogenous leukemia. Cancer Genet Cytogenet. 132:133–135. 2002. View Article : Google Scholar : PubMed/NCBI
12	Gmidène A, Frikha R, Sennana H, Elghezal H, Elloumi M and Saad A: T(1;21;8)(p34;q22;q22): A novel variant of t(8;21) in acute myeloblastic leukemia with maturation. Med Oncol. 28 (Suppl 1):S509–S512. 2011. View Article : Google Scholar : PubMed/NCBI
13	Al Bahar S, Adriana Z and Pandita R: A novel variant translocation t(6;8;21)(p22;q22;q22) leading to AML/ETO fusion in acute myeloid leukemia. Gulf J Oncolog. 56–59. 2009.PubMed/NCBI
14	Tay Za K, Shanmugam H and Chin EFM: A new complex translocation (8;22;21)(q22;q12;q22) in RUNX1/RUNX1T1 acute myeloid leukaemia. Malays J Pathol. 41:333–338. 2019.PubMed/NCBI
15	Mishra SR, Rawal L, Othman MAK, Thatai A, Sarkar A, Lal V and Bhattacharya SK: Complex rearrangement in acute myeloid leukemia M2 with RUNX1/RUNX1T1 fusion involving chromosomes 8, 17 and 21. Mol Cytogenet. 14:282021. View Article : Google Scholar : PubMed/NCBI
16	Akhila Raj TV, Gopinath P, Geetha Raj JA, Narayanan G, Nair SG, Joy Philip DS, Raveendran S, Geetha P and Sreedharan H: Acute myeloid leukemia patients with variant or unusual translocations involving chromosomes 8 and 21-A comprehensive cytogenetic profiling of three cases with review of literature. J Cancer Res Ther. 18:697–703. 2022. View Article : Google Scholar : PubMed/NCBI
17	Han B, Jing Y, Bi X, Lin Y, Li H, Li H, Ru K and Yang S: t(2;2;21;8)(p21;q37;q22;q22), a novel four-way complex translocation involving variant t(8;21) in case of acute myeloid leukemia: A case report and literature review. Cancer Genet. 284-285:1–4. 2024. View Article : Google Scholar : PubMed/NCBI
18	Wu SP, Costello R, Hofmann JN, Korde N, Mailankody S, Purdue M and Landgren O: MGUS prevalence in a cohort of AML patients. Blood. 122:294–295. 2013. View Article : Google Scholar : PubMed/NCBI
19	Luca DC and Almanaseer IY: Simultaneous presentation of multiple myeloma and acute monocytic leukemia. Arch Pathol Lab Med. 127:1506–1508. 2003. View Article : Google Scholar : PubMed/NCBI
20	Wang LQ, Li H, Li XX, Li FL, Wang LL, Chen XL and Hou M: A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma. BMC Cancer. 15:7242015. View Article : Google Scholar : PubMed/NCBI
21	Kim D, Kwok B and Steinberg A: Simultaneous acute myeloid leukemia and multiple myeloma successfully treated with allogeneic stem cell transplantation. South Med J. 103:1246–1249. 2010. View Article : Google Scholar : PubMed/NCBI
22	Platanias LC: Map kinase signaling pathways and hematologic malignancies. Blood. 101:4667–4679. 2003. View Article : Google Scholar : PubMed/NCBI
23	Lloyd MC, Cunningham JJ, Bui MM, Gillies RJ, Brown JS and Gatenby RA: Darwinian dynamics of intratumoral heterogeneity: Not solely random mutations but also variable environmental selection forces. Cancer Res. 76:3136–3144. 2016. View Article : Google Scholar : PubMed/NCBI